about
Richter transformation of CLL.Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.Risk of second cancers in survivors of prolymphocytic leukemia: a SEER data analysis.Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.Richter transformation with c-MYC overexpression: report of three cases.FDG-PET imaging in hematological malignanciesRichter Transformation of Chronic Lymphocytic Leukemia: A Review of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography and Molecular DiagnosticsRisk factors for Richter syndrome in chronic lymphocytic leukemia.Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review.Secondary immunodeficiency in lymphoproliferative malignancies.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.Periorbital Richter Syndrome.NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.Ibrutinib and rituximab induced rapid response in refractory Richter syndromeConcomitant Presence of CD5-Positive Diffuse Large B-Cell Lymphoma and Monoclonal B Cells with the "CLL Immunophenotype" - Is It Richter's Transformation?Ibrutinib has some activity in Richter's syndromeThe efficacy of ibrutinib in the treatment of Richter syndrome.Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome.A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.Bilateral acute orbital compartment syndrome secondary to Richter syndrome: the 'tulip' sign.Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia.Extranodal Richter's syndrome of the urinary bladder
P2860
Q30249283-71CA8B8C-BC3E-449F-B3FF-C5621C7E7CC6Q30841807-1D42C154-C727-4692-8FA6-10376664E5EFQ31147302-CBF1BCA4-051A-431C-8B19-F70550F964A7Q35626311-97E03BE4-1D77-46BA-822A-7CA08E081B77Q35919565-0498A634-9522-41F4-823B-2C2BF0FF436AQ37632114-144D4EF7-5D9E-4620-AFF4-630E916ADE73Q37632830-C45AA13C-B106-4DAB-B5C5-17151B6C402CQ38248873-AE9E05EA-1C8B-4DB8-A757-BF4712F3C805Q38263924-D89A0DFE-45FC-48F4-8698-AE17A1D95927Q38877593-A49CD50B-ACDD-4611-A0B6-20C98C103CCFQ38893343-2181ABA2-D0BD-467A-A601-2D4A77E1C755Q38896306-C7C253E0-1FD9-4DA2-A46E-8C0F1E1BABDCQ38962267-E8B21D7A-7A8B-4712-9FAD-C8EF5405FDA9Q39025300-0724B5E2-1D33-4DED-80BA-3FF98686AC38Q39034465-6677D042-A4D2-4FBF-A4FF-3EC542D66CF7Q40291554-4F55D59A-F932-48AF-9267-2B22962E61A2Q40955026-81888934-0BB1-4186-97D0-2B64E3DB1F06Q41481956-796A9634-C45E-47F4-89F3-DEE16DBB024EQ41775352-D90298BA-020B-4112-8AA5-A2128CE39E0CQ41819322-9DD5E658-2FD8-4F85-A550-C6165A3B18C5Q42091318-B44A77ED-071B-4411-93E6-29EF012A69E6Q42250734-7D1DB7E4-E783-4343-86CD-643EB69A0A87Q42358968-563BA130-927A-4322-99CF-5AA02ED21E89Q43178455-F84BB6B5-3F3B-4CEB-A141-EDC97EEEBF28Q48112267-9E894204-6925-449B-878F-00140F4E792AQ48168654-8C977380-415D-4E1A-8062-D56576F49AC6Q48204203-90E75FF0-A110-4B90-8400-68BD60EDDF61Q48310393-FE80A11F-0599-45B7-AFBA-17D75F1F6F66Q50074012-29B83407-5D4A-4997-BA05-8A6F89602249Q50716088-47CBCBAC-ADA4-4461-BC7B-FA3B797CC467Q52983745-66814642-B1FA-4A98-A568-117F096ECDB3Q54975035-66C8E059-C930-406A-9357-BB0997E2A110Q58593603-42ED76C3-F337-4810-BCBC-940272C1D348
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How we treat Richter syndrome.
@en
How we treat Richter syndrome.
@nl
type
label
How we treat Richter syndrome.
@en
How we treat Richter syndrome.
@nl
prefLabel
How we treat Richter syndrome.
@en
How we treat Richter syndrome.
@nl
P2093
P2860
P1433
P1476
How we treat Richter syndrome.
@en
P2093
Neil E Kay
Sameer A Parikh
Tait D Shanafelt
P2860
P304
P356
10.1182/BLOOD-2013-11-516229
P407
P577
2014-01-13T00:00:00Z